Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New eye injection could stop corneal blood vessels in their tracks

NCT ID NCT07329686

First seen Jan 10, 2026 · Last updated May 17, 2026 · Updated 20 times

Summary

This study tests a new way to deliver anti-VEGF drugs directly into the cornea to treat abnormal blood vessel growth caused by herpes simplex keratitis. The approach aims to be more targeted and longer-lasting than standard treatments. About 100 adults who have not had prior anti-VEGF therapy or corneal surgery will participate. The goal is to see if this injection is safe and effective at reducing blood vessels, improving vision, and clearing the cornea.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HERPES SIMPLEX KERATITIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • 1 Xihu Avenue, Shangcheng District,Hangzhou, Zhejiang,China,Hangzhou, Zhejiang Completed

    RECRUITING

    Hangzhou, Zhejiang, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.